![]() | Up a level |
Bregenzer, Andrea; Bruggmann, Philip; Castro, Erika; Moriggia, Alberto; Rothen, Madeleine; Thurnheer, Maria Christine; Vernazza, Pietro; Scheidegger, Claude (2021). Hepatitis C virus elimination in Swiss opioid agonist therapy programmes - the SAMMSU cohort. Swiss medical weekly, 151, w20460. EMH Media 10.4414/smw.2021.20460
Noguera-Julian, Marc; Cozzi-Lepri, Alessandro; Di Giallonardo, Francesca; Schuurman, Rob; Däumer, Martin; Aitken, Sue; Ceccherini-Silberstein, Francesca; D'Arminio Monforte, Antonella; Geretti, Anna Maria; Booth, Claire L; Kaiser, Rolf; Michalik, Claudia; Jansen, Klaus; Masquelier, Bernard; Bellecave, Pantxika; Kouyos, Roger D; Castro, Erika; Furrer, Hansjakob; Schultze, Anna; Günthard, Huldrych F; ... (2016). Contribution of APOBEC3G/F Activity to the Development of Low-Abundance Drug-Resistant HIV-1 variants. Clinical microbiology and infection, 22(2), pp. 191-200. Blackwell Publishing 10.1016/j.cmi.2015.10.004
Cozzi-Lepri, Alessandro; Noguera-Julian, Marc; Di Giallonardo, Francesca; Schuurman, Rob; Däumer, Martin; Aitken, Sue; Ceccherini-Silberstein, Francesca; D'Arminio Monforte, Antonella; Geretti, Anna Maria; Booth, Clare L; Kaiser, Rolf; Michalik, Claudia; Jansen, Klaus; Masquelier, Bernard; Bellecave, Pantxika; Kouyos, Roger D; Castro, Erika; Furrer, Hansjakob; Schultze, Anna; Günthard, Huldrych F; ... (2015). Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing. Journal of antimicrobial chemotherapy, 70(3), pp. 930-940. Oxford University Press 10.1093/jac/dku426